GO:0040013 negative regulation of locomotion: Signaling Brakes, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0040013 negative regulation of locomotion describes any process that stops, prevents, or reduces the frequency, rate or extent of locomotion of a cell or organism.
• It is a biological_process term whose synonyms include down regulation of locomotion, down-regulation of locomotion, downregulation of locomotion, and inhibition of locomotion.
• Key molecular brakes include Rho GTPase regulators such as p190RhoGAP and GEFs for RhoA, which control actin dynamics at the leading edge of migrating cells.
• Negative regulation of locomotion is essential for development, immune cell navigation, wound healing, and preventing cancer metastasis.
• Dysregulation of this process contributes to tumor invasion, chronic inflammation, and impaired tissue repair.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in negative regulation of locomotion.
Description
Locomotion is a fundamental behavior of cells and organisms, but uncontrolled movement is dangerous. GO:0040013 negative regulation of locomotion is the biological process that stops, prevents, or reduces the frequency, rate or extent of locomotion of a cell or organism. This term captures the molecular brakes that keep migration in check, from Rho GTPase signaling at the leading edge to cytokine-driven feedback loops in keratinocytes. Understanding these brakes is critical because their failure underlies cancer invasion, chronic inflammation, and defective wound repair. Researchers studying negative regulation of locomotion need to identify which genes act as brakes, how they are switched on and off, and what happens when they are lost. This article synthesizes authoritative QuickGO annotation data with real PubMed literature to provide a research-grade overview of the term, its mechanisms, key genes, disease links, and experimental methods.
negative regulation of locomotion At A Glance
| GO ID | GO:0040013 |
|---|---|
| GO term | negative regulation of locomotion |
| Ontology | biological_process |
| Synonym | down regulation of locomotion; down-regulation of locomotion; downregulation of locomotion; inhibition of locomotion |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of locomotion of a cell or organism |
| Related processes | Regulation of cell migration, Rho GTPase signaling, actin cytoskeleton organization |
| Example regulators | p190RhoGAP, RhoA GEFs, SOCS3/CIS3, Fbxw7β, miR-192 |
| Disease relevance | Cancer metastasis, chronic inflammation, impaired wound healing |
What Is GO:0040013?
In simple terms, negative regulation of locomotion is the set of biological processes that slow down or stop movement. According to the QuickGO definition, it is any process that stops, prevents, or reduces the frequency, rate or extent of locomotion of a cell or organism. This includes molecular signals that inhibit actin polymerization at the leading edge, phosphatases that switch off motility kinases, and secreted factors that dampen chemotaxis. The term is a biological_process and is often studied alongside its positive counterpart, positive regulation of locomotion.
Why Is negative regulation of locomotion Important in Cell Biology?
Negative regulation of locomotion is important because it provides the essential braking system for cell and organism movement. Without it, cells migrate excessively, leading to tumor invasion and metastasis, while organisms may fail to position tissues correctly during development. In the immune system, negative regulation of locomotion helps resolve inflammation by limiting neutrophil and keratinocyte migration. In tissue repair, controlled inhibition of migration ensures that wound healing stops at the right time. Thus, understanding GO:0040013 is central to developmental biology, cancer research, immunology, and regenerative medicine.
• Prevents uncontrolled cell migration that can lead to cancer metastasis.
• Balances positive and negative signals during embryonic development.
• Limits excessive immune cell infiltration and chronic inflammation.
• Coordinates wound healing by stopping keratinocyte migration at the right time.
• Regulates axon guidance and sensory neuron gain control in C. elegans.
• Controls myoblast differentiation and proliferation during muscle regeneration.
• Provides targets for anti-metastatic therapies.
• Helps maintain tissue architecture by restricting cells to their proper niches.
• Is essential for proper organogenesis and morphogenesis.
• Offers mechanistic insights into Rho GTPase signaling at the leading edge.
What Happens During negative regulation of locomotion?
Initiation of inhibitory signaling
In simple terms: The cell receives a stop signal.
Negative regulation of locomotion begins when extracellular or intracellular cues activate inhibitory receptors or phosphatases. For example, the antimicrobial peptide LL-37 can transactivate the epidermal growth factor receptor to induce keratinocyte migration, but negative regulators such as SOCS3/CIS3 are induced to limit STAT3-driven motility. In C. elegans, the calcineurin TAX-6 provides negative regulation and gain control of sensory neurons. These initial signals set the stage for downstream cytoskeletal changes.
Rho GTPase inactivation at the leading edge
In simple terms: Molecular switches that drive movement are turned off.
A central step is the inactivation of Rho GTPases, particularly RhoA, at the leading edge of migrating cells. p190RhoGAP is a GTPase-activating protein that converts active RhoA-GTP to inactive RhoA-GDP, thereby reducing actin stress fiber formation and limiting protrusion. Phosphorylation-mediated regulation of guanine nucleotide exchange factors (GEFs) for RhoA also controls the balance between active and inactive RhoA. This step directly reduces the frequency and rate of locomotion.
Actin cytoskeleton remodeling
In simple terms: The cell's internal skeleton is reorganized to stop forward movement.
Inactivation of RhoA leads to decreased actin polymerization and reduced formation of lamellipodia and filopodia. p190RhoGAP activity at the leading edge promotes actin disassembly and retraction. Similarly, Fbxw7β, an E3 ubiquitin ligase, negatively regulates primary myoblast differentiation, proliferation and migration, likely through ubiquitin-mediated degradation of motility-promoting proteins. These cytoskeletal changes physically prevent the cell from moving forward.
Transcriptional and post-transcriptional feedback
In simple terms: The cell changes which genes are made to sustain the stop signal.
Negative regulation of locomotion is reinforced by transcriptional and post-transcriptional mechanisms. miR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein, which reduces migration. SOCS3/CIS3 negatively regulates STAT3 in HGF-induced keratinocyte migration, providing a feedback loop that dampens motility. These layers ensure that the inhibitory signal is sustained and not easily reversed.
Resolution and return to stationary state
In simple terms: The cell settles down and stops moving.
Ultimately, the combined actions of GTPase inactivation, cytoskeletal remodeling, and gene expression changes return the cell to a stationary state. In sensory neurons, TAX-6 calcineurin provides gain control to prevent overstimulation. In keratinocytes, SOCS3/CIS3 induction limits HGF-induced migration. This resolution phase is critical for normal tissue homeostasis and preventing pathological migration.
Key Genes Involved in GO:0040013 negative regulation of locomotion
The following genes and proteins are experimentally validated regulators of negative regulation of locomotion (GO:0040013).
| Gene | Major Role | Research Relevance |
|---|---|---|
| ARHGAP35 (p190RhoGAP) | GTPase-activating protein for RhoA; inactivates RhoA at the leading edge | Key brake for cell migration; studied in cancer and development |
| RHOA | Small GTPase controlling actin cytoskeleton; active form promotes motility | Central switch; its inactivation is a hallmark of negative regulation |
| SOCS3 | Suppressor of cytokine signaling; negatively regulates STAT3 in HGF-induced migration | Feedback inhibitor of keratinocyte migration |
| CIS3 | Suppressor of cytokine signaling; similar to SOCS3 | Negative regulator of STAT3-driven motility |
| FBXW7β | E3 ubiquitin ligase; negative regulation of myoblast differentiation, proliferation and migration | Controls muscle regeneration |
| MIR192 | MicroRNA; suppresses tumorigenicity by targeting NIN1 binding protein | Inhibits prostate cancer cell migration |
| TAX-6 | Calcineurin; negative regulation and gain control of sensory neurons | Model for neuronal locomotion control |
| EGFR | Receptor tyrosine kinase; transactivated by LL-37 to induce keratinocyte migration | Upstream of negative feedback loops |
| STAT3 | Transcription factor; promotes migration; inhibited by SOCS3/CIS3 | Target of negative regulation |
| NIN1 (NIN1BP) | Target of miR-192; involved in tumorigenicity | Potential biomarker in prostate cancer |
| LL-37 | Antimicrobial peptide; induces keratinocyte migration via EGFR | Triggers negative feedback |
| HGF | Hepatocyte growth factor; induces keratinocyte migration | Induces SOCS3/CIS3 negative regulation |
| RhoA GEFs | Guanine nucleotide exchange factors; activate RhoA | Phosphorylation-mediated regulation controls motility |
| p190RhoGAP | See ARHGAP35 | Regulates Rho GTPase activity at leading edge |
| Fbxw7 | E3 ubiquitin ligase family | Negative regulation of myoblast migration |
| Calcineurin | Phosphatase; TAX-6 in C. elegans | Negative regulation of sensory neurons |
| STAT3 pathway | Cytokine signaling | Negatively regulated by SOCS3/CIS3 |
| Rho GTPase | Family of small GTPases | Central to locomotion control |
How Is negative regulation of locomotion Regulated?
Negative regulation of locomotion is itself regulated at multiple levels. Phosphorylation of RhoA GEFs modulates their activity, thereby controlling the balance between active and inactive RhoA. p190RhoGAP activity is regulated by its localization and phosphorylation state at the leading edge. Cytokine signaling through STAT3 is negatively regulated by SOCS3/CIS3, which are induced by HGF and provide a feedback brake on keratinocyte migration. In C. elegans, the calcineurin TAX-6 provides gain control of sensory neurons, preventing overstimulation. These regulatory layers ensure that locomotion is tightly controlled in space and time.
negative regulation of locomotion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ARHGAP35 (p190RhoGAP) | Cancer metastasis | Knockout in cancer cell lines; migration assays |
| MIR192 | Prostate cancer | Overexpression in prostate cancer cells; tumorigenicity assays |
| FBXW7β | Muscle regeneration disorders | Knockout in myoblasts; differentiation and migration assays |
| SOCS3 | Chronic inflammation, impaired wound healing | Knockout in keratinocytes; STAT3 signaling assays |
| TAX-6 | Sensory neuron disorders | C. elegans knockout; neuronal gain control assays |
Cancer metastasis
Loss of negative regulation of locomotion allows cancer cells to migrate and invade. miR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein, reducing migration. Fbxw7β negatively regulates myoblast migration, and its dysregulation may contribute to tumor progression. p190RhoGAP, by inactivating RhoA, acts as a brake on migration; its loss is associated with increased invasiveness.
Chronic inflammation and impaired wound healing
In keratinocytes, HGF-induced migration is negatively regulated by SOCS3/CIS3, which inhibit STAT3. LL-37 induces keratinocyte migration via EGFR transactivation, but negative feedback limits excessive migration. Dysregulation of these brakes can lead to chronic inflammation or impaired wound healing.
Neurological and developmental disorders
In C. elegans, the calcineurin TAX-6 provides negative regulation and gain control of sensory neurons. Disruption of such negative regulation could contribute to sensory processing disorders. Additionally, Fbxw7β controls myoblast migration, linking negative regulation of locomotion to muscle development.
From negative regulation of locomotion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of p190RhoGAP increase cell migration? | CRISPR knockout of ARHGAP35 in cancer cell lines |
| Does miR-192 overexpression suppress migration? | Overexpression of MIR192 in prostate cancer cells |
| Does Fbxw7β negatively regulate myoblast migration? | Knockout of FBXW7β in myoblasts |
| Does SOCS3 feedback inhibit STAT3-driven migration? | Knockout of SOCS3 in keratinocytes |
| Does TAX-6 control sensory neuron gain? | Knockout of tax-6 in C. elegans |
| Does phosphorylation of RhoA GEFs affect motility? | Point mutations in GEF phosphorylation sites |
How to Study the negative regulation of locomotion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Rate of cell movement through a membrane | Quantify negative regulation of locomotion |
| Time-lapse microscopy | Frequency and speed of cell migration | Live-cell tracking of migrating cells |
| RhoA activity pull-down | Ratio of active RhoA-GTP to total RhoA | Measure p190RhoGAP activity |
| Phospho-specific immunoblot | Phosphorylation status of GEFs | Assess regulation of RhoA GEFs |
| RNA-seq | Transcriptional changes | Identify genes altered during negative regulation |
| Luciferase reporter assay | miRNA target validation | Confirm miR-192 targeting of NIN1 |
| CRISPR knockout screen | Gene essentiality for migration | Discover novel negative regulators |
| Wound healing assay | Collective cell migration | Study SOCS3/CIS3 in keratinocytes |
Live-cell imaging and migration assays
Time-lapse microscopy and transwell migration assays are used to quantify the frequency and rate of locomotion. These methods directly measure the effect of negative regulators such as p190RhoGAP on cell migration. Wound healing assays in keratinocytes can assess SOCS3/CIS3-mediated inhibition of HGF-induced migration.
Rho GTPase activity assays
GTPase activity is measured using pull-down assays or FRET biosensors. These methods detect the conversion of RhoA-GTP to RhoA-GDP by p190RhoGAP. Phosphorylation of GEFs can be assessed by immunoblotting with phospho-specific antibodies.
Transcriptional and post-transcriptional profiling
RNA-seq and miRNA profiling identify changes in genes such as MIR192 and SOCS3 during negative regulation of locomotion. Luciferase reporter assays validate miRNA targets like NIN1.
Genetic screens and CRISPR libraries
CRISPR knockout libraries can systematically identify genes that negatively regulate locomotion. Candidate genes such as ARHGAP35, FBXW7β, and SOCS3 can be validated in focused screens.
How CRISPR Can Be Used to Study GO:0040013 negative regulation of locomotion
Knockout
CRISPR knockout of negative regulators such as ARHGAP35, FBXW7β, or SOCS3 removes the brakes on locomotion, leading to increased migration. These models are used to test causality in cancer and wound healing.
Point Mutation
Point mutations can be introduced into phosphorylation sites of RhoA GEFs to test how specific residues control negative regulation of locomotion. Similarly, mutations in the catalytic domain of p190RhoGAP can abolish its GAP activity.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci allows real-time tracking of proteins like p190RhoGAP at the leading edge. This approach preserves endogenous regulation.
Overexpression
Overexpression of MIR192 or SOCS3 can enhance negative regulation of locomotion and suppress migration. These models are useful for testing therapeutic potential.
How EDITGENE Supports negative regulation of locomotion Research
Researchers studying negative regulation of locomotion-related genes often need to determine whether a candidate gene is causally involved in stopping or slowing cell movement. EDITGENE provides the CRISPR tools and services to build precisely engineered cell models for such causal tests.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of locomotion research.
Frequently Asked Questions About negative regulation of locomotion
What is GO:0040013 negative regulation of locomotion?
GO:0040013 is a Gene Ontology biological_process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of locomotion of a cell or organism.
What genes are involved in negative regulation of locomotion?
Key genes include ARHGAP35 (p190RhoGAP), RHOA, SOCS3, CIS3, FBXW7β, MIR192, and TAX-6.
How does p190RhoGAP regulate cell migration?
p190RhoGAP inactivates RhoA by converting GTP to GDP, reducing actin polymerization and limiting protrusion at the leading edge.
What is the role of SOCS3 in keratinocyte migration?
SOCS3/CIS3 negatively regulates STAT3 in HGF-induced keratinocyte migration, providing a feedback brake.
How does miR-192 suppress prostate cancer?
miR-192 suppresses tumorigenicity by targeting and inhibiting nin one binding protein, reducing migration.
What is the function of Fbxw7β in myoblasts?
Fbxw7β is an E3 ubiquitin ligase that negatively regulates primary myoblast differentiation, proliferation and migration.
How is RhoA activity regulated by phosphorylation?
Phosphorylation-mediated regulation of GEFs for RhoA controls the balance between active and inactive RhoA.
What is the role of TAX-6 in sensory neurons?
TAX-6 calcineurin provides negative regulation and gain control of sensory neurons in C. elegans.
How can CRISPR be used to study negative regulation of locomotion?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in negative regulation of locomotion.
What diseases are linked to defective negative regulation of locomotion?
Cancer metastasis, chronic inflammation, impaired wound healing, and neurological disorders.
Conclusion
GO:0040013 negative regulation of locomotion is a critical biological process that provides the brakes for cell and organism movement. Its molecular basis involves Rho GTPase inactivation, cytoskeletal remodeling, and transcriptional feedback loops. Dysregulation of these brakes contributes to cancer, inflammation, and developmental disorders. By combining QuickGO annotations with real PubMed literature, this article provides a research-grade resource for scientists studying locomotion control. EDITGENE offers comprehensive CRISPR services to build the cell models needed to advance this field.
References
- 1. Bidaud-Meynard A et al.. 2019. Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP.. Small GTPases 10(2):99-110 PMID: 28287334
- 2. Sun J et al.. 2016. MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.. Int J Mol Med 37(2):485-92 PMID: 26743688
- 3. Shin K et al.. 2017. Fbxw7β, E3 ubiquitin ligase, negative regulation of primary myoblast differentiation, proliferation and migration.. Anim Sci J 88(4):712-719 PMID: 27594513
- 4. Patel M et al.. 2014. Phosphorylation-mediated regulation of GEFs for RhoA.. Cell Adh Migr 8(1):11-8 PMID: 24589508
- 6. Tokumaru S et al.. 2005. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37.. J Immunol 175(7):4662-8 PMID: 16177113
- 7. Kuhara A et al.. 2002. Negative regulation and gain control of sensory neurons by the C. elegans calcineurin TAX-6.. Neuron 33(5):751-63 PMID: 11879652
- 8. Tokumaru S et al.. 2005. SOCS3/CIS3 negative regulation of STAT3 in HGF-induced keratinocyte migration.. Biochem Biophys Res Commun 327(1):100-5 PMID: 15629435
